January 7, 2024- by Steven E. Greer, MD
Researchers led by UCSF studied in a cohort the effects of Pfizer’s Paxlovid on COVID patients outside of the hospital.
“Individuals treated with Paxlovid, (21%) reported rebound symptoms. Among those who repeated antigen testing after testing negative and completing treatment, (25.7%) reported rebound test positivity.”
Click here for the full paper